Sultana Mh Faradz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sultana Mh Faradz has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
Achmad Zulfa Juniarto
7 shared publications- Tri Indah Winarni
Diponegoro University, Indonesia
7 shared publications Mahayu Dewi Ariani
6 shared publicationsArdy Santosa
5 shared publicationsNurin Aisyiyah Listyasari
Division of Human Genetics, Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
5 shared publications- Agustini Utari
Center for Biomedical Research (CEBIOR), Faculty of Medicine, Diponegoro University, Semarang, Indonesia
4 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Journal of Biomedicine and Translational Research
- Vol. 12 (2) , 141-147
Detection of TSPY Gene in Turner Syndrome and Its Variants
Background: One X chromosome deletion, either total or partial, is linked to the uncommon disorder known as Turner Syndrome. This condition frequently results in mosaic karyotypes. Conventional cytogenetic approaches for karyotype analysis may fail to detect low–level Y chromosome mosaicism. The use of molecular analysis as a foundational technique to evaluate Y-chromosome segments in patients with Turner has increased. A cell line with a Y-chromosome is present in approximately 5% of the patients, which is undetectable by the standard cytogenetic analysis. Molecular detection of TSPY (Testis Specific protein Y-linked) gene located at Yp11.2 has been done to detect chromosome Y materials and had been used to predict the risk of gonadoblastoma.Objective: To identify TSPY gene in patients with Turner Syndrome and its variants.Methods: DNA samples from 22 Turner Syndrome patients were undergone PCR amplification to detect TSPY gene.Results: There were 13 (59%) patients with 45 X and mosaic X karyotypes, while TSPY gene was not amplified. There is no hidden Y chromosome constituent was found. The remaining 9 (41%) patients had mosaic 46,XY. TSPY gene was able to be detected and amplified.Conclusion: PCR analysis show no hidden Y chromosome in monosomy X and mosaic 46,XX groups. Identification of TSPY gene by molecular analysis offers an applicable and challenging management. This approach plays a vital role in facilitating the diagnosis and management of Turner syndrome patients with mosaicism, especially in laboratories that lack of cytogenetic capabilities. These findings support in management, including genetic counseling of Turner Syndrome patients.
- 12 May 2026
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Journal of Biomedicine and Translational Research
- Vol. 12 (2) , 141-147
Open AccessDetection of TSPY Gene in Turner Syndrome and Its Variants
Background: One X chromosome deletion, either total or partial, is linked to the uncommon disorder known as Turner Syndrome. This condition frequently results in mosaic karyotypes. Conventional cytogenetic approaches for karyotype analysis may fail to detect low–level Y chromosome mosaicism. The use of molecular analysis as a foundational technique to evaluate Y-chromosome segments in patients with Turner has increased. A cell line with a Y-chromosome is present in approximately 5% of the patients, which is undetectable by the standard cytogenetic analysis. Molecular detection of TSPY (Testis Specific protein Y-linked) gene located at Yp11.2 has been done to detect chromosome Y materials and had been used to predict the risk of gonadoblastoma.Objective: To identify TSPY gene in patients with Turner Syndrome and its variants.Methods: DNA samples from 22 Turner Syndrome patients were undergone PCR amplification to detect TSPY gene.Results: There were 13 (59%) patients with 45 X and mosaic X karyotypes, while TSPY gene was not amplified. There is no hidden Y chromosome constituent was found. The remaining 9 (41%) patients had mosaic 46,XY. TSPY gene was able to be detected and amplified.Conclusion: PCR analysis show no hidden Y chromosome in monosomy X and mosaic 46,XX groups. Identification of TSPY gene by molecular analysis offers an applicable and challenging management. This approach plays a vital role in facilitating the diagnosis and management of Turner syndrome patients with mosaicism, especially in laboratories that lack of cytogenetic capabilities. These findings support in management, including genetic counseling of Turner Syndrome patients.
- 1 January 2026
- Published by S. Karger AG in Sexual Development
- Vol. 20 (1-6) , 95-101
WT1 Deletion in 46,XY DSD: The Importance of Copy Number Variant Analysis
Introduction: Diagnostic copy number variants (CNVs) have been detected in up to 30% of individuals with DSD. Tools have been developed to detect CNVs from exome/genome sequencing. Methods: Sequencing data from a cohort of individuals with DSD were re-analysed through a CNV-caller (Ximmer) after no diagnostic single nucleotide variants were identified through traditional sequencing analysis. Results: A deletion was identified for an individual with gonadal dysgenesis that encompassed all exons of the gene WT1. Conclusion: This case reinforces the role of CNV analysis as part of genomic analysis, which holds exciting potential for improving diagnostic rates in the future.
- 1 January 2026
- Published by S. Karger AG in Sexual Development
- Vol. 20 (1-6) , 95-101
WT1 Deletion in 46,XY DSD: The Importance of Copy Number Variant Analysis
Introduction: Diagnostic copy number variants (CNVs) have been detected in up to 30% of individuals with DSD. Tools have been developed to detect CNVs from exome/genome sequencing. Methods: Sequencing data from a cohort of individuals with DSD were re-analysed through a CNV-caller (Ximmer) after no diagnostic single nucleotide variants were identified through traditional sequencing analysis. Results: A deletion was identified for an individual with gonadal dysgenesis that encompassed all exons of the gene WT1. Conclusion: This case reinforces the role of CNV analysis as part of genomic analysis, which holds exciting potential for improving diagnostic rates in the future.
- Open Access
- 28 November 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Journal of Biomedicine and Translational Research
- Vol. 11 (3) , 113-118
Low sEng Level in Preeclampsia with MFTHFR Gene Polymorphism Suggesting a Protective Factor
Background: Preeclampsia is one of the most serious complications of pregnancy and the leading cause of maternal and fetal mortality. Various studies have shown that Glutathione Peroxidase (GPx) deficiency and increased Soluble endoglin (sEng) level are consistently associated with the incidence of preeclampsia. Several studies also show the role of MTHFR A1298C and C677T gene polymorphisms in preeclampsia.Objective: This study investigated association between blood GPx, sEng levels, MTHFR A1298C and C677T gene polymorphisms in Preeclampsia.Methods: This analytic observational case-control study was conducted on 70 cases of preeclampsia and 70 controls. Blood GPx and sEng levels were measured using Enzyme Linked Immunosorbent Assay (ELISA). MTHFR A1298C and C677T gene polymorphism was genotyped using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). The data obtained were analyzed using the Mann-Whitney U test, chi-square test, and independent T-test.Results: There were no significant differences in GPx levels or MTHFR A1298C/C677T genotype distribution between groups. sEng levels were significantly higher in the preeclampsia group than controls (p=0.001). ROC analysis identified a cut-off of 7.75 ng/mL. Among preeclampsia patients, those with the MTHFR 1298AC/CC genotypes had lower sEng levels than wildtype (p=0.027), suggesting a potential protective effect. No association was found for C677T.Conclusion: We found no significant difference in GPx level, MTHFR A1298C and C677T gene polymorphism between preeclampsia and control group. Soluble endoglin (sEng) level in the preeclampsia group (mean: 11.0±5.22) were significantly different (p=0.001) compared to the control group (mean: 8.1±5.31). Increased level of sEng is associated with incidence of preeclampsia. A key finding in this study is the significantly lower sEng levels observed in preeclampsia patients carrying the MTHFR 1298AC and 1298CC alleles compared to the control group (p=0.027). This indicates a protective factor where in preeclampsia with MTHFR gene alleles 1298AC and 1298CC sEng levels are lower compared to wildtype.
- 28 November 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Journal of Biomedicine and Translational Research
- Vol. 11 (3) , 113-118
Open AccessLow sEng Level in Preeclampsia with MFTHFR Gene Polymorphism Suggesting a Protective Factor
Background: Preeclampsia is one of the most serious complications of pregnancy and the leading cause of maternal and fetal mortality. Various studies have shown that Glutathione Peroxidase (GPx) deficiency and increased Soluble endoglin (sEng) level are consistently associated with the incidence of preeclampsia. Several studies also show the role of MTHFR A1298C and C677T gene polymorphisms in preeclampsia.Objective: This study investigated association between blood GPx, sEng levels, MTHFR A1298C and C677T gene polymorphisms in Preeclampsia.Methods: This analytic observational case-control study was conducted on 70 cases of preeclampsia and 70 controls. Blood GPx and sEng levels were measured using Enzyme Linked Immunosorbent Assay (ELISA). MTHFR A1298C and C677T gene polymorphism was genotyped using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). The data obtained were analyzed using the Mann-Whitney U test, chi-square test, and independent T-test.Results: There were no significant differences in GPx levels or MTHFR A1298C/C677T genotype distribution between groups. sEng levels were significantly higher in the preeclampsia group than controls (p=0.001). ROC analysis identified a cut-off of 7.75 ng/mL. Among preeclampsia patients, those with the MTHFR 1298AC/CC genotypes had lower sEng levels than wildtype (p=0.027), suggesting a potential protective effect. No association was found for C677T.Conclusion: We found no significant difference in GPx level, MTHFR A1298C and C677T gene polymorphism between preeclampsia and control group. Soluble endoglin (sEng) level in the preeclampsia group (mean: 11.0±5.22) were significantly different (p=0.001) compared to the control group (mean: 8.1±5.31). Increased level of sEng is associated with incidence of preeclampsia. A key finding in this study is the significantly lower sEng levels observed in preeclampsia patients carrying the MTHFR 1298AC and 1298CC alleles compared to the control group (p=0.027). This indicates a protective factor where in preeclampsia with MTHFR gene alleles 1298AC and 1298CC sEng levels are lower compared to wildtype.
- Open Access
- 4 October 2025
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 23 (4) , 100582
Detection of FMR1 CGG Repeat Expansions Using Buccal Swab and Blood Samples of Children With Intellectual Disability in A Resource-Limited Country
- 4 October 2025
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 23 (4) , 100582
Open AccessDetection of FMR1 CGG Repeat Expansions Using Buccal Swab and Blood Samples of Children With Intellectual Disability in A Resource-Limited Country
- Open Access
- 12 September 2025
- Published by Faculty of Medicine Prince of Songkla University in Journal of Health Science and Medical Research
- p. 20251251
Pathogenic Variants in TUBGCP6 of Familial Microcephaly and Chorioretinopathy
Microcephaly and chorioretinopathy type 1 (MCCRP1) is an autosomal recessive syndrome characterized by severe microcephaly, facial dysmorphisms, chorioretinopathy, and developmental delays. This rare condition is caused by homozygous or compound heterozygous pathogenic variants in the Tubulin Gamma Complex Component 6 (TUBGCP6) gene. We present 2 siblings from a non-consanguineous family in Indonesia diagnosed with MCCRP1. Both had a history of intrauterine growth retardation (IUGR) and were born with microcephaly and low birth weight. They exhibited developmental delays and hyperactive behavior. Facial dysmorphisms included upslanting palpebral fissures, strabismus, long philtrum, and a low anterior hairline. Ophthalmologic examination revealed chorioretinopathy in both siblings, while cardiac and hearing evaluations were normal. Microarray analysis revealed no likely pathogenic copy number variants (CNVs). Whole exome sequencing (WES) was performed on DNA from the siblings and their parents. The variant analysis identified a paternal pathogenic splice variant c.2066-6A>G and a maternal pathogenic nonsense variant c.3393G>A in the TUBGCP6 gene (NM_020461.4) in both siblings, indicating a compound heterozygous variant. This is the first case report of familial MCCRP1 in Indonesia, presenting both clinical features and genetic analysis of the TUBGCP6 gene.
- 12 September 2025
- Published by Faculty of Medicine Prince of Songkla University in Journal of Health Science and Medical Research
- p. 20251251
Open AccessPathogenic Variants in TUBGCP6 of Familial Microcephaly and Chorioretinopathy
Microcephaly and chorioretinopathy type 1 (MCCRP1) is an autosomal recessive syndrome characterized by severe microcephaly, facial dysmorphisms, chorioretinopathy, and developmental delays. This rare condition is caused by homozygous or compound heterozygous pathogenic variants in the Tubulin Gamma Complex Component 6 (TUBGCP6) gene. We present 2 siblings from a non-consanguineous family in Indonesia diagnosed with MCCRP1. Both had a history of intrauterine growth retardation (IUGR) and were born with microcephaly and low birth weight. They exhibited developmental delays and hyperactive behavior. Facial dysmorphisms included upslanting palpebral fissures, strabismus, long philtrum, and a low anterior hairline. Ophthalmologic examination revealed chorioretinopathy in both siblings, while cardiac and hearing evaluations were normal. Microarray analysis revealed no likely pathogenic copy number variants (CNVs). Whole exome sequencing (WES) was performed on DNA from the siblings and their parents. The variant analysis identified a paternal pathogenic splice variant c.2066-6A>G and a maternal pathogenic nonsense variant c.3393G>A in the TUBGCP6 gene (NM_020461.4) in both siblings, indicating a compound heterozygous variant. This is the first case report of familial MCCRP1 in Indonesia, presenting both clinical features and genetic analysis of the TUBGCP6 gene.
- Open Access
- 28 April 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Journal of Biomedicine and Translational Research
- Vol. 11 (1) , 7-12
Genetic Counselling Empowers Parents of Children with Intellectual Disabilities : A Fragile X Syndrome Perspective
Background: Intellectual disabilities (ID) profoundly affect individuals and their families, leading to financial strain, emotional distress, and limited access to healthcare and education. Fragile X Syndrome (FXS), the most common inherited cause of ID, remains largely underdiagnosed in Indonesia due to limited awareness and resources. Objective: This study aimed to assess the impact of genetic counselling on parental empowerment. Methods: This pre-experimental study employed a before and after counselling. A total of 238 parents of children with ID from four special schools in Jakarta participated. Data were collected using the Genetic Counselling Outcome Scale-24 (GCOS-24), which assesses empowerment. Purposive sampling was applied, and data were analysed using paired t-tests and one-way ANOVA. Results: The mean GCOS-24 score increased significantly from 106.79 (SD = 16.36) before counselling to 125.11 (SD = 15.42) after counselling (p < 0.001). Only 27.3% of parents were aware of genetic disorders, reflecting their limited baseline knowledge. A one-way ANOVA analysis showed a statistically significant difference in GCOS-24 score improvements based on parental education level (F=4.035, p=0.008) with parents with primary school education showing the greatest improvement compared to those with high school (p < 0.05). Conclusions: Genetic counselling significantly enhanced parent empowerment, as evidenced by increased GCOS-24 scores. These findings emphasize the importance of expanding genetic counselling services and educational initiatives in Indonesia to improve awareness and support for families managing ID.
- 28 April 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Journal of Biomedicine and Translational Research
- Vol. 11 (1) , 7-12
Open AccessGenetic Counselling Empowers Parents of Children with Intellectual Disabilities : A Fragile X Syndrome Perspective
Background: Intellectual disabilities (ID) profoundly affect individuals and their families, leading to financial strain, emotional distress, and limited access to healthcare and education. Fragile X Syndrome (FXS), the most common inherited cause of ID, remains largely underdiagnosed in Indonesia due to limited awareness and resources. Objective: This study aimed to assess the impact of genetic counselling on parental empowerment. Methods: This pre-experimental study employed a before and after counselling. A total of 238 parents of children with ID from four special schools in Jakarta participated. Data were collected using the Genetic Counselling Outcome Scale-24 (GCOS-24), which assesses empowerment. Purposive sampling was applied, and data were analysed using paired t-tests and one-way ANOVA. Results: The mean GCOS-24 score increased significantly from 106.79 (SD = 16.36) before counselling to 125.11 (SD = 15.42) after counselling (p < 0.001). Only 27.3% of parents were aware of genetic disorders, reflecting their limited baseline knowledge. A one-way ANOVA analysis showed a statistically significant difference in GCOS-24 score improvements based on parental education level (F=4.035, p=0.008) with parents with primary school education showing the greatest improvement compared to those with high school (p < 0.05). Conclusions: Genetic counselling significantly enhanced parent empowerment, as evidenced by increased GCOS-24 scores. These findings emphasize the importance of expanding genetic counselling services and educational initiatives in Indonesia to improve awareness and support for families managing ID.
- Open Access
- 20 March 2025
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 26 (1) , 1-9
Genetic counselling of disorders of sex development (DSD) in low middle income country (LMIC): case studies
Background: Disorders of Sex Development (DSD) are a group of conditions associated with atypical development of internal and external genitalia. Identifying the underlying cause of DSD is crucial for diagnosis and long-term individualized approach for management and counselling. Social issues which are major obstacles in individuals with DSD include sex/gender identification, obtaining birth certificate, school registration, national identity card and finding an appropriate job. In DSD, the most important problem is gender assignment and subsequent decision of treatment with medication, hormonal therapy and surgery. Case presentation: Three patients with DSD were selected from our clinic because of very late consultation and complex psychological problem. These cases were Complete Androgen Insensivity syndrome (CAIS), Congenital Adrenal Hyperplasia (CAH) and DAX-1 duplication with suffering of gender dysphoria. They were late identified therefore chromosomal and molecular examination were carried out when puberty was reached. Conclusion: Genetic counsellors play an important role in addressing the issues of individuals with DSD and their families. To the best of our knowledge this is the first genetic counseling assessment on late identified DSD cases. They would take into account while counseling, the cultural, religious, psychosocial and legal issues. Genetic counsellors would also consider family views and choices before offering the appropriate management and treatment options. This paper highlights the genetic counselling aspects for individuals with DSD and their families in countries with a conservative cultural and religious milieu.
- 20 March 2025
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 26 (1) , 1-9
Open AccessGenetic counselling of disorders of sex development (DSD) in low middle income country (LMIC): case studies
Background: Disorders of Sex Development (DSD) are a group of conditions associated with atypical development of internal and external genitalia. Identifying the underlying cause of DSD is crucial for diagnosis and long-term individualized approach for management and counselling. Social issues which are major obstacles in individuals with DSD include sex/gender identification, obtaining birth certificate, school registration, national identity card and finding an appropriate job. In DSD, the most important problem is gender assignment and subsequent decision of treatment with medication, hormonal therapy and surgery. Case presentation: Three patients with DSD were selected from our clinic because of very late consultation and complex psychological problem. These cases were Complete Androgen Insensivity syndrome (CAIS), Congenital Adrenal Hyperplasia (CAH) and DAX-1 duplication with suffering of gender dysphoria. They were late identified therefore chromosomal and molecular examination were carried out when puberty was reached. Conclusion: Genetic counsellors play an important role in addressing the issues of individuals with DSD and their families. To the best of our knowledge this is the first genetic counseling assessment on late identified DSD cases. They would take into account while counseling, the cultural, religious, psychosocial and legal issues. Genetic counsellors would also consider family views and choices before offering the appropriate management and treatment options. This paper highlights the genetic counselling aspects for individuals with DSD and their families in countries with a conservative cultural and religious milieu.
- Open Access
- 12 September 2023
- Published by S. Karger AG in Sexual Development
- Vol. 17 (4-6) , 170-180
Lessons Learned from 17 Years of Multidisciplinary Care for Differences of Sex Development Patients at a Single Indonesian Center
Background: Our multidisciplinary team (MDT) is a large specialized team based in Semarang, Indonesia, that cares for a wide variety of pediatric and adult individuals with differences of sex development (DSD) from across Indonesia. Here, we describe our work over the last 17 years. Methods: We analyzed phenotypic, hormonal, and genetic findings from clinical records for all patients referred to our MDT during the period 2004–2020. Results: Among 1,184 DSD patients, 10% had sex chromosome DSD, 67% had 46,XY DSD, and 23% had 46,XX DSD. The most common sex chromosome anomaly was Turner syndrome (45,X) (55 cases). For patients with 46,XY DSD under-masculinization was the most common diagnosis (311 cases), and for 46,XX DSD, a defect of Müllerian development was most common (131 cases) followed by congenital adrenal hyperplasia (CAH) (116 cases). Sanger sequencing, MLPA, and targeted gene sequencing of 257 patients with 46,XY DSD found likely causative variants in 21% (55 cases), with 13 diagnostic genes implicated. The most affected gene codes for the androgen receptor. Molecular analysis identified a diagnosis for 69 of 116 patients with CAH, with 62 carrying variants in CYP21A2 including four novel variants, and 7 patients carrying variants in CYP11B1. In many cases, these genetic diagnoses influenced the clinical management of patients and their families. Conclusions: Our work has highlighted the occurrence of different DSDs in Indonesia. By applying sequencing technologies as part of our clinical care, we have delivered a number of genetic diagnoses and identified novel pathogenic variants in some genes, which may be clinically specific to Indonesia. Genetics can inform many aspects of DSD clinical management, and while many of our patients remain undiagnosed, we hope that future testing may provide answers for even more.
- 12 September 2023
- Published by S. Karger AG in Sexual Development
- Vol. 17 (4-6) , 170-180
Open AccessLessons Learned from 17 Years of Multidisciplinary Care for Differences of Sex Development Patients at a Single Indonesian Center
Background: Our multidisciplinary team (MDT) is a large specialized team based in Semarang, Indonesia, that cares for a wide variety of pediatric and adult individuals with differences of sex development (DSD) from across Indonesia. Here, we describe our work over the last 17 years. Methods: We analyzed phenotypic, hormonal, and genetic findings from clinical records for all patients referred to our MDT during the period 2004–2020. Results: Among 1,184 DSD patients, 10% had sex chromosome DSD, 67% had 46,XY DSD, and 23% had 46,XX DSD. The most common sex chromosome anomaly was Turner syndrome (45,X) (55 cases). For patients with 46,XY DSD under-masculinization was the most common diagnosis (311 cases), and for 46,XX DSD, a defect of Müllerian development was most common (131 cases) followed by congenital adrenal hyperplasia (CAH) (116 cases). Sanger sequencing, MLPA, and targeted gene sequencing of 257 patients with 46,XY DSD found likely causative variants in 21% (55 cases), with 13 diagnostic genes implicated. The most affected gene codes for the androgen receptor. Molecular analysis identified a diagnosis for 69 of 116 patients with CAH, with 62 carrying variants in CYP21A2 including four novel variants, and 7 patients carrying variants in CYP11B1. In many cases, these genetic diagnoses influenced the clinical management of patients and their families. Conclusions: Our work has highlighted the occurrence of different DSDs in Indonesia. By applying sequencing technologies as part of our clinical care, we have delivered a number of genetic diagnoses and identified novel pathogenic variants in some genes, which may be clinically specific to Indonesia. Genetics can inform many aspects of DSD clinical management, and while many of our patients remain undiagnosed, we hope that future testing may provide answers for even more.
- Open Access
- 31 May 2023
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Intractable & Rare Diseases Research
- Vol. 12 (2) , 104-113
Genetic diagnostic approach to intellectual disability and multiple congenital anomalies in Indonesia
Intellectual disability (ID) and multiple congenital anomalies (MCA) are major contributors to infant mortality, childhood morbidity, and long-term disability, with multifactorial aetiology including genetics. We aim to set a diagnostic approach for genetic evaluation of patients with ID and MCA, which can be applied efficiently with a good diagnostic rate in Indonesia or other low resources settings. Out of 131 ID cases, twenty-three individuals with ID/global developmental delay (GDD) and MCA were selected from two-steps of dysmorphology screening and evaluation. Genetic analysis included chromosomal microarray (CMA) analysis, targeted panel gene sequencing, and exome sequencing (ES). CMA revealed conclusive results for seven individuals. Meanwhile, two out of four cases were diagnosed by targeted gene sequencing. Five out of seven individuals were diagnosed using ES testing. Based on the experience, a novel and comprehensive flowchart combining thorough physical and dysmorphology evaluation, followed by suitable genetic tests is proposed as a diagnostic approach to elucidate the genetic factor(s) of ID/GDD and MCA in low resources settings such as Indonesia.
- 31 May 2023
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Intractable & Rare Diseases Research
- Vol. 12 (2) , 104-113
Open AccessGenetic diagnostic approach to intellectual disability and multiple congenital anomalies in Indonesia
Intellectual disability (ID) and multiple congenital anomalies (MCA) are major contributors to infant mortality, childhood morbidity, and long-term disability, with multifactorial aetiology including genetics. We aim to set a diagnostic approach for genetic evaluation of patients with ID and MCA, which can be applied efficiently with a good diagnostic rate in Indonesia or other low resources settings. Out of 131 ID cases, twenty-three individuals with ID/global developmental delay (GDD) and MCA were selected from two-steps of dysmorphology screening and evaluation. Genetic analysis included chromosomal microarray (CMA) analysis, targeted panel gene sequencing, and exome sequencing (ES). CMA revealed conclusive results for seven individuals. Meanwhile, two out of four cases were diagnosed by targeted gene sequencing. Five out of seven individuals were diagnosed using ES testing. Based on the experience, a novel and comprehensive flowchart combining thorough physical and dysmorphology evaluation, followed by suitable genetic tests is proposed as a diagnostic approach to elucidate the genetic factor(s) of ID/GDD and MCA in low resources settings such as Indonesia.
- 1 January 2023
- Vol. 55 (1) , 87-94
Pituitary Macroadenoma in a Girl with Male Karyotype: A Rare Case Study
Macroadenoma is a tumor that typically develops in the epithelial cells of the pituitary gland. Patients suffering from the condition are often asymptomatic with complaints that are caused by hormonal imbalance. Therefore, chromosome analysis needs to be done to females aged >16 years presenting with amenorrhea. Karyotype 46,XY is a disorder of sex development (DSD) that is caused by the complex process of gene interactions, androgen synthesis, and hormone regulation.The patient initially came to the hospital for a scheduled transsphenoidal surgery due to pituitary macroadenoma, and later complained of primary amenorrhea and atypical external genital. Furthermore, physical examination of genitalia revealed mild clitoromegaly without obvious introitus vagina. Laboratory testing showed elevated prolactin and testosterone level, while ultrasonography imaging revealed the absence of the uterus and ovaries. The brain magnetic resonance imaging (MRI) demonstrated a pituitary adenoma, and cytogenetic analysis showed 46,XYkaryotype. Subsequently, hyperprolactinemia, imaging, and histopathology examination were used to confirm pituitary macroadenoma in the patient. It was assumed that the undermasculinized genitalia was caused by hormonal disorders including the deficiency of androgen action or 5-alpha-reductase enzyme. 46,XYDSD has many different symptoms, hence, clinicians need to be aware of potential multifactorial aetiologies. Imaging of internal genitalia, hormonal and chromosomal analysis should be carried out to assess patients with unknown causes of the disorder. Molecular analysis needs to be carried to exclude the possible gene mutation.
- 1 January 2023
- Vol. 55 (1) , 87-94
Pituitary Macroadenoma in a Girl with Male Karyotype: A Rare Case Study
Macroadenoma is a tumor that typically develops in the epithelial cells of the pituitary gland. Patients suffering from the condition are often asymptomatic with complaints that are caused by hormonal imbalance. Therefore, chromosome analysis needs to be done to females aged >16 years presenting with amenorrhea. Karyotype 46,XY is a disorder of sex development (DSD) that is caused by the complex process of gene interactions, androgen synthesis, and hormone regulation.The patient initially came to the hospital for a scheduled transsphenoidal surgery due to pituitary macroadenoma, and later complained of primary amenorrhea and atypical external genital. Furthermore, physical examination of genitalia revealed mild clitoromegaly without obvious introitus vagina. Laboratory testing showed elevated prolactin and testosterone level, while ultrasonography imaging revealed the absence of the uterus and ovaries. The brain magnetic resonance imaging (MRI) demonstrated a pituitary adenoma, and cytogenetic analysis showed 46,XYkaryotype. Subsequently, hyperprolactinemia, imaging, and histopathology examination were used to confirm pituitary macroadenoma in the patient. It was assumed that the undermasculinized genitalia was caused by hormonal disorders including the deficiency of androgen action or 5-alpha-reductase enzyme. 46,XYDSD has many different symptoms, hence, clinicians need to be aware of potential multifactorial aetiologies. Imaging of internal genitalia, hormonal and chromosomal analysis should be carried out to assess patients with unknown causes of the disorder. Molecular analysis needs to be carried to exclude the possible gene mutation.